Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ngan

Showing results (121-130 of 293) with videos related to

Pageof 30
Sort By:
Oncotarget|March 25, 2014
Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancerMichelle X Liu, Michelle K Y Siu, Stephanie S Liu, et al.
Endocrinology|October 8, 2005
Endocrine gland-derived vascular endothelial growth factor is expressed in human peri-implantation endometrium, but not in endometrial carcinomaElly S W Ngan, K Y Lee, William S B Yeung, et al.
Cancer Cell International|May 11, 2018
Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancerKaren K L Chan, Michelle K Y Siu, Yu-Xin Jiang, et al.
The Journal of Obstetrics and Gynaecology Research|September 16, 2011
Human papillomavirus vaccine: what are women most concerned about?Karen K L Chan, Tracy T C Kwan, Tzy-Jyun Yao, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|July 6, 2023
Awareness, perceptions, and acceptance of human papillomavirus vaccination among parents in Hong KongE W H Lam, H Y S Ngan, K Y Kun, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 20, 2021
Diagnosis and management of gestational trophoblastic disease: 2021 updateHextan Y S Ngan, Michael J Seckl, Ross S Berkowitz, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 12, 2018
Update on the diagnosis and management of gestational trophoblastic diseaseHextan Y S Ngan, Michael J Seckl, Ross S Berkowitz, et al.
European Journal of Cancer Care|September 5, 2020
Nurse-led follow-up in survivorship care of gynaecological malignancies-A randomised controlled trialSiew-Fei Ngu, Na Wei, Justin Li, et al.
Oncotarget|June 27, 2016
Extremely stringent activation of p16INK4a prevents immortalization of uterine cervical epithelial cells without human papillomavirus oncogene expressionSu Hang, Agnes F Y Tiwari, Hextan Y S Ngan, et al.
Journal of Medical Virology|February 5, 2015
HPV 16 E2 binding sites 1 and 2 become more methylated than E2 binding site 4 during cervical carcinogenesisTsin-Wah Leung, Stephanie S Liu, Rebecca C Y Leung, et al.
Pageof 30

Showing results (121-130 of 293) with videos related to

Sort By:
Pageof 30
Oncotarget|March 25, 2014
Epigenetic silencing of microRNA-199b-5p is associated with acquired chemoresistance via activation of JAG1-Notch1 signaling in ovarian cancerMichelle X Liu, Michelle K Y Siu, Stephanie S Liu, et al.
Endocrinology|October 8, 2005
Endocrine gland-derived vascular endothelial growth factor is expressed in human peri-implantation endometrium, but not in endometrial carcinomaElly S W Ngan, K Y Lee, William S B Yeung, et al.
Cancer Cell International|May 11, 2018
Estrogen receptor modulators genistein, daidzein and ERB-041 inhibit cell migration, invasion, proliferation and sphere formation via modulation of FAK and PI3K/AKT signaling in ovarian cancerKaren K L Chan, Michelle K Y Siu, Yu-Xin Jiang, et al.
The Journal of Obstetrics and Gynaecology Research|September 16, 2011
Human papillomavirus vaccine: what are women most concerned about?Karen K L Chan, Tracy T C Kwan, Tzy-Jyun Yao, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|July 6, 2023
Awareness, perceptions, and acceptance of human papillomavirus vaccination among parents in Hong KongE W H Lam, H Y S Ngan, K Y Kun, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 20, 2021
Diagnosis and management of gestational trophoblastic disease: 2021 updateHextan Y S Ngan, Michael J Seckl, Ross S Berkowitz, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|October 12, 2018
Update on the diagnosis and management of gestational trophoblastic diseaseHextan Y S Ngan, Michael J Seckl, Ross S Berkowitz, et al.
European Journal of Cancer Care|September 5, 2020
Nurse-led follow-up in survivorship care of gynaecological malignancies-A randomised controlled trialSiew-Fei Ngu, Na Wei, Justin Li, et al.
Oncotarget|June 27, 2016
Extremely stringent activation of p16INK4a prevents immortalization of uterine cervical epithelial cells without human papillomavirus oncogene expressionSu Hang, Agnes F Y Tiwari, Hextan Y S Ngan, et al.
Journal of Medical Virology|February 5, 2015
HPV 16 E2 binding sites 1 and 2 become more methylated than E2 binding site 4 during cervical carcinogenesisTsin-Wah Leung, Stephanie S Liu, Rebecca C Y Leung, et al.
Pageof 30